87 results
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
20 May 24
Pulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000
4:10pm
, statements concerning early clinical successes and whether they are predictive of the safety and efficacy of any medical device such as the CellFX
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
to continue current operations as planned, statements concerning early clinical successes and whether they are predictive of the safety and efficacy of any
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
9 May 24
Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
9:09am
with our unique proprietary technology, giving them the potential to set new standards for safety and efficacy as well as decreased workflow time from … clinical successes and whether they are predictive of the safety and efficacy of any medical device such as the CellFX nsPFA Percutaneous Electrode System
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
7 May 24
Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results
4:14pm
concerning early clinical successes and whether they are predictive of the safety and efficacy of any medical device such as the CellFX nsPFA 360° Cardiac
8-K
EX-99.1
if8uq
28 Mar 24
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
4:18pm
8-K
EX-99.1
147bdfqa
11 Mar 24
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
9:10am
8-K
EX-99.1
p7j8oo3mmxw 5xj8
14 Feb 24
Other Events
9:22am
8-K
EX-99.1
7ntqw94e
2 Jan 24
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clamp
9:20am
8-K
EX-99.1
zlp5orflr13gtx9i
20 Dec 23
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter
9:06am
8-K
5u2bsejphoyqk
27 Nov 23
Regulation FD Disclosure
9:08am
8-K
EX-99.1
whka4hz x2
21 Nov 23
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
9:03am